Research Grants - 1991
 

Total Grants Awarded for Year: $782,260
(derived from Grants and You, KCOM faculty and staff principal investigators are listed in bold font)

Baer, Robert W., Ph.D. (Physiology). $30,910 (year 03). American Heart Association, National Center. July 1991 - June 1992. Coronary transcapillary exchange.

Bolonos, Conny, Class of 1994, Alan K. Willingham, Ph.D., and Richard J. Cenedella, Ph.D. (Faculty Sponsors, Biochemistry). $2,880. July 1991 - June 1992. The effect of high doses of vitamin E on the progression of atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit.

Buckley, Arthur R., Ph.D. (Pharmacology). $10,000. Pharmaceutical Manufacturers Association Foundation, Inc. Jan. 1991 - Dec. 1991. Nuclear C-kinase: mechanism of cyclosporine inhibition.

Byrnes, Thomas, D.O. and Michael L. Kuchera, D.O. (Faculty Sponsor, Osteopathic Manipulative Medicine). $5,000. American Osteopathic Association/Burroughs Wellcome Osteopathic Research Fellowship. July 1991 - June 1992. Prospective/retrospective evaluation of hospital OMT consult findings and viscerosomatic correlations with administration and disease diagnosis.

Cenedella, Richard J., Ph.D. (Biochemistry). $127,309 (year 14). National Institutes of Health. Sept. 1991 - Aug. 1992. Lens cholesterol metabolism and the U18666A cataract.

Chamberlain, Neal R., Ph.D. (Microbiology/Immunology). $3,800. KCOM Warner Fund. July 1991 - June 1993. Purification of fatty acid modifying enzyme from Staphylococcus aureus.

Chamberlain, Neal R., Ph.D. (Microbiology/Immunology). $23,000. Eli Lilly. Sept. 1991 - Aug. 1992. Development of a Staphylococcus aureus strain pair useful in an antibacterial screen of membrane damaging agents.

Geisbuhler, Timothy P., Ph.D. (Physiology). $51,675 (year 05). National Institutes of Health-First Award. Dec. 1991 - June 1992. Metabolism of guanosine in ischemic myocardium.

Horn, Michael, D.O. (Osteopathic Manipulative Medicine). $2,000. Cranial Academy. July 1991 - June 1992. The effects of osteopathic manipulative treatment (CV4 technique) on human plasma growth hormone.

Kuchera, Michael L., D.O., FAAO (Osteopathic Manipulative Medicine). $166,280 Anonymous. Jan. 1991 - Dec. 1991. KCOM Levitor program.

Lo, Kim Sing, D.O. (Osteopathic Manipulative Medicine). $5,000. National Osteopathic Foundation - Mead Johnson Fellowship Grant. July 1991 - June 1992. Manipulative treatment in fibromyalgia syndrome.

Lo, Kim Sing, D.O. and Michael L. Kuchera, D.O. (Faculty Sponsor, Osteopathic Manipulative Medicine). $5,000. American Osteopathic Association/Burroughs Wellcome Osteopathic Research Fellowship. July 1991 - June 1992. Osteopathic manipulative treatment in fibromyalgia syndrome.

Martin, John R., Ph.D. (Pharmacology). $103,316. National Heart, Lung, and Blood Institute-AREA Award. Apr. 1991 - Mar. 1994. Baroreflex and posterior hypothalamic neuropeptide-Y.

Rearick, James I., Ph.D. (Biochemistry). $3,800. KCOM Warner Fund. July 1991 - June 1993. Purification of cholesterol sulfotransferase.

Sargentini, Neil J., Ph.D. (Microbiology/Immunology). $88,681. National Institutes of Health/Stanford University. Sept. 1991 - Sept. 1992. Effects of umuC, O₂ and OH on -radiation mutagenesis.

Sexton, William L., Ph.D. (Physiology). $25,000. American Heart Association, Missouri Affiliate. July 1991 - June 1992. Microcirculatory transport capacity in skeletal muscle of diabetic rats.

Theobald, Robert J., Ph.D. (Pharmacology). $1,900. KCOM Warner Fund. July 1991 - June 1992. Effect of Reactive Blue 2 and Coomassie Brilliant Blue G on purine inhibition of bladder contractions.

Towns, Lex C., Ph.D. (Anatomy). $5,000 National Institutes of Health. Sept. 1991 - Aug. 1992. Small instrumentation program.

Uray, Nandor J., Ph.D. (Anatomy). $119,759 (year 04). Alcohol, Drug Abuse, and Mental health Administration. Sept. 1991 - Aug. 1994. Ethanol-hormonal interactions in cerebellar development.

Willingham, Allan K., Ph.D. (Biochemistry). $1,950. KCOM Warner Fund. July 1991 - June 1992. The effect of high doses of vitamin E on the progression of atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit.

*Written by or with assistance from the Office of Grants and Program Development and/or the Office of Research Support.